Results 51 to 60 of about 2,860,764 (308)

Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings

Journal of Patient-Reported Outcomes, 2022
Background There is interest in participants using their own smartphones or tablets (“bring your own device”; BYOD) to complete patient-reported outcome (PRO) measures in clinical studies.
Louise Newton, Oliver Knight-West, Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, Tara Symonds, David S. Reasner, Bill Byrom, Paul O’Donohoe, Susan Vallow, the Patient-Reported Outcome (PRO) Consortium, Electronic Clinical Outcome Assessment (eCOA) Consortium   +11 more
doaj   +1 more source

Patient reported outcome measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review [PDF]

, 2019
Symptomatic and functional recovery are important patient-reported outcome measures (PROMs) in community-acquired pneumonia (CAP) that are increasingly used as trial endpoints.
Bolton, Charlotte E., Lim, Wei Shen, McKeever, Tricia M., Pick, Harry J.   +3 more
core   +2 more sources

Rapid Response to Trametinib Combined With Chemotherapy for Infant BRAF‐Fused Chiasmatic Glioma

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Infants, less than 1 year, with chiasmatic gliomas (ICG) present a major therapeutic challenge due to large tumor size, decreased vision, rapid progression, and poor response to vincristine/carboplatin chemotherapy. The majority have a BRAF fusion, which may respond to downstream MEK inhibitors but response time is slow. There are no safety or
Helen Toledano, Alexander Yelak, Walid Kaadan, Shlomo Caduri, Rivka Friedland, Orli Michaeli, Gad Dotan, Osnat Konen   +7 more
wiley   +1 more source

Does scrolling affect measurement equivalence of electronic patient-reported outcome measures (ePROM)? Results of a quantitative equivalence study

Journal of Patient-Reported Outcomes, 2021
Background Scrolling is a perceived barrier in the use of bring your own device (BYOD) to capture electronic patient reported outcomes (ePROs). This study explored the impact of scrolling on the measurement equivalence of electronic patient-reported ...
Saeid Shahraz, Tan P. Pham, Marc Gibson, Marie De La Cruz, Munther Baara, Sachin Karnik, Christopher Dell, Sheryl Pease, Suyash Nigam, Joseph C. Cappelleri, Craig Lipset, Patrick Zornow, Jeff Lee, Bill Byrom   +13 more
doaj   +1 more source

a protocol for developing a patient-reported outcome measurement instrument [PDF]

, 2016
Introduction: There is no consensus about what constitutes the most appropriate patient-reported outcome measurement (PROM) instrument for measuring physical function in patients with rheumatic hand conditions.
Bliddal, Henning, Christensen, Robin, Gershon, Richard, Haugen, Ida K., Henriksen, Marius, Kjeken, Ingvild, Klokker, Louise, Kloppenburg, Marg, Liegl, Gregor, Nolte, Sandra, Schalet, Ben, Terwee, Caroline B., Waehrens, Eva Ejlersen, Westhoven, Rene, Wittoek, Ruth   +14 more
core   +1 more source

Patient-Reported Outcomes and Fibromyalgia [PDF]

Rheumatic Disease Clinics of North America, 2016
Fibromyalgia (FM) is classified as a chronic pain condition accompanied by symptoms of fatigue, sleep problems, problems with cognition, negative mood, limited functional status, and the presence of other chronic overlapping pain conditions. Comprehensive assessment of all of these components can be challenging.
David A, Williams, Anna L, Kratz
openaire   +2 more sources

Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Cognitive and psychological difficulties could negatively interfere with treatment adherence and quality of life before and after hematopoietic stem cell transplant (HSCT). Methods to mitigate these changes may have positive effects on treatment success.
Kristen L. Votruba, Michelle Rozwadowski, Thomas Braun, April Rahrig, Edward Peres, Kirsten M. Williams, Vanessa Fabrizio, Julie‐An Talano, Carrie L. Kitko, Nicolas Parnell, Pavan Reddy, Sung Won Choi   +11 more
wiley   +1 more source

Extending the Range of Measurement for Minimally Invasive Treatments by Adding New Concepts to FACE-Q Aesthetics Scales

Plastic and Reconstructive Surgery, Global Open
Background:. The Satisfaction with Face Overall and Psychological Function scales are the most frequently used FACE-Q Aesthetics module scales. This study aimed to extend their range of measurement by adding and testing new concepts.
Anne F. Klassen, DPhil, Andrea L. Pusic, MD, Manraj Kaur, PhD, Charlene Rae, PhD, Lotte Poulsen, MD, PhD, Jasmine Mansouri, BSc, Elena Tsangaris, PhD, Steven Dayan, MD, Jennifer Klok, MD, Kathleen Armstrong, MD, Katherine Santosa, MD, Stefan Cano, PhD, CPsychol, AFBPsS   +11 more
doaj   +1 more source

Patient-reported outcome measures for cancer caregivers: a systematic review [PDF]

, 2016
Purpose Informal caregivers provide invaluable help and support to people with cancer. As treatments extend survival and the potential burdens on carers increase, there is a need to assess the impact of the role.
A Girgis, A Girgis, A Lafaye, B Cooper, BA Given, BR Ferrell, BS Fletcher, C Nijboer, CW Given, DW Sherman, EK Grov, ER Giovannetti, G Can, IJ Higginson, JF Deeken, JI Cameron, KJ McKee, Lesley Fallowfield, LL Northouse, Lucy Matthews, M Glajchen, M Glajchen, M Stommel, MA Weitzner, MA Weitzner, MA Weitzner, MT Oberst, P Minaya, PJ Haylock, R Cohen, R Fitzpatrick, R Lazarus, RC Macefield, RE Stein, S Khanjari, S Schur, SD Lambert, SH Zarit, SH Zarit, U Stenberg, Valerie Jenkins, Valerie Shilling, WB Brouwer, WB Brouwer, Y Kim, YG Bachner, YS Rhee   +46 more
core   +1 more source

A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT A second allogeneic (allo‐)hematopoietic stem cell transplantation (HSCT2) is a potential curative option for pediatric patients with acute lymphoblastic leukemia (ALL) following relapse after first allogeneic transplantation (HSCT1), but its efficacy is limited by high relapse rates and transplant‐related toxicity in highly pretreated ...
Ava Momm, Imme Haubitz, Rita Beier, Martin Zimmermann, Andrej Lissat, Peter Bader, Matthias Eyrich, Jan‐Henning Klusmann, Matthias Wölfl, Paul‐Gerhardt Schlegel, Verena Wiegering   +10 more
wiley   +1 more source